FdaApplication
NDA 213004
Identifiers
- fda_app_no: NDA213004
Properties
| Property | Value |
|---|---|
| applicant_name | TALICIA HOLDINGS INC |
| application_type | NDA |
| approval_date | 2019-11-01 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TALICIA | AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN | 250MG;EQ 10MG BASE;12.5MG | CAPSULE, DELAYED RELEASE;ORAL |
1 product